Video

An engineered enzyme cleaved and repaired age-related protein damage in human tissue, which was long thought to be irreversible in a proof-of-concept study.

A brain-computer interface paired with electrical stimulation patches helped a paralyzed man regain hand strength, dexterity, and his sense of touch.

A new peptide-based vaccine elicited antigen-specific T cell responses in high-risk patients, demonstrating proof of concept for PDAC intervention. 

Thousands of cyclosporiasis cases across dozens of US states triggered investigations, but the exact contamination source remains elusive.

Explore how immune cell populations are reshaped within the tumor microenvironment and how in vivo models can guide the development of next-generation combination immunotherapies.

Explore an integrated workflow that combines AI-guided antibody design with automated biophysical characterization to accelerate antibody discovery from design to experimental validation in under five weeks.